Clinical Trial

Thromboelastography to Study Burn Coagulopathy

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
No participants enrolled
Summary
This pilot study examines the use of thromboelastography (TEG), a specialized blood test, to evaluate clotting abnormalities in burn patients. The study aims to understand how burn injuries impact the body's ability to form and break down blood clots over time. Specifically, the investigators will research whether the percentage of total body surface area burned (%TBSA) is associated with changes in blood clotting, track the evolution of clotting patterns during the first four weeks following a burn injury, and explore whether these changes can predict recovery or complications. By providing new insights into clotting dynamics in burn patients, the study seeks to improve diagnostic methods, enhance monitoring strategies, and guide treatments to optimize patient care and outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-10.
Status change: Not Yet Recruiting → Withdrawn 2026-07-20
Trial Details
NCT Number NCT06879509
Lead Sponsor Francesco Egro
Conditions Burn, Coagulation, Blood
Start Date 2026-01-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-02-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-22